Association Between Venous Excess Ultrasound Grading System and Acute Kidney Injury in the ICU Population

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

About this trial

Fluid resuscitation is one of the cornerstones of treatment in ICU patients. Nonetheless, excessive fluid administration can lead to fluid overload which has been associated with worse outcomes in the ICU. To prevent this, assessments of fluid responsiveness are commonly employed. However, fluid responsiveness does not take fluid tolerance into account. Fluid tolerance is the idea that a patient might still be fluid responsive but might already be at risk of the detrimental effects of fluid therapy. Recent developments in point of care ultrasound e.g. the Venous excess ultrasound might help identify patients at risk of fluid overload. However its association with patient relevant outcomes in the ICU remains unclear.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

all patients admitted to the ICU 18 years or older expected to stay in the ICU for more than 24 hours

Disqualifiers

any obstruction between the righ atrium and structures assessed by VExUS

a medical history of: Major cardiac shunts (e.g. atrial septum defect), Tricuspid regurgitation, dialysis, portal hypertension, pulmonary hypertension, interstitial lung disease, recipients of a kidney of liver transplant.

patients in whom an ultrasound assesment is unfeasible e.g. a BMI over 40

Trial population

All cricitally ill patients who are expected to be admitted to the ICU for more than 24 hours and who do not meet the exclusion criteria

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Rate of acute kidney injury

Clinically relevant acute kidney injury in the ICU: a 200% rise in creatinine or the use of renal replacement therapy

Time frame
within 30 days of admission to the ICU
2

Mortality

death of all causes

Time frame
within 30 days of admission to the ICU
3

Rate of MAKE-30

a composite endpoint of mortality and acute kidney injury ( including renal replacement therapy)

Time frame
within 30 days of admission to the ICU

Secondary outcomes

Other outcomes

1

Lung ultrasound score

a score for lung aeration as assessed by ultrasound ranging from 0 to 36 where 0 is the normal physiological state

Time frame
maximum of 3 times during the first 7 days of admission
2

Cardiac function as assed by ultrasound

determined by eyeballing and measurement of the tricuspid annular plane systolic excursion (\>16 is normal)

Time frame
maximum of 3 times during the first 7 days of admission

Sponsors and contacts

Click on the lead sponsor to view all of their trials.